Tools

Combining the drug gemtuzumab ozogamicin (GO) with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children… »   

U.S. health regulators on Wednesday approved a drug to treat a rare and aggressive form of non-Hodgkin lymphoma developed by… »   

An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in… »   

U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals, a U.S.-based unit of Japanese drugmaker Dainippon… »   

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with… »   

Roche’s newly approved leukemia drug Gazyva helped patients live nearly a year longer without the disease worsening than the drugmaker’s… »   

Geron Corp said 22 percent of trial patients treated with its experimental blood cancer drug were now free of the… »   

About 120 million people around the world with Type 2 diabetes - and two million in Canada - take the… »   

U.S. regulators said on Friday they approved a new treatment from Roche Holding AG for patients with chronic lymphocytic leukemia… »   

Previously untreated patients experienced significant and lasting reductions in signs and symptoms of psoriatic arthritis when given Celgene Corp’s experimental… »